foxo4 dri senolytic peptide human trial 2024 2025 Class II senolytics inhibit survival pathways elicited by senescent general inflammation SS-31 Reconstitution: 5mg + Strength:2000mcg
SKU: 90551011893
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 16 - Sep 21